#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA615512	F	Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 30 uM	Mus musculus	4		cell-based format	Scientific Literature
2.	ALA631233	P	Hydrophilicity was determined		4		small-molecule physicochemical format	Scientific Literature
3.	ALA629144	P	Partition coefficient (logP)		13		small-molecule physicochemical format	Scientific Literature
4.	ALA635447	P	Partition coefficient (logP)		29		assay format	Scientific Literature
5.	ALA632264	P	Dissociation constant measured by potentiometric titration (in duplicate) in 1:1 dioxane-water using a Fisher accumet pH meter model 630 and a Perkin-Elmer chart recorder model 56.		13		small-molecule physicochemical format	Scientific Literature
6.	ALA875362	P	Ionization constant for the compound		4		small-molecule physicochemical format	Scientific Literature
7.	ALA647871	B	in vitro aldose reductase inhibitory activity measured by NADPH-dependent inhibition of glyceraldehyde reduction in a partially purified bovine lens preparation at 10e -6M conc.		1		single protein format	Scientific Literature
8.	ALA648019	B	in vitro aldose reductase inhibitory activity measured by NADPH-dependent inhibition of glyceraldehyde reduction in a partially purified bovine lens preparation at 10e -7M conc.; g=no inhibitory activity		1		single protein format	Scientific Literature
9.	ALA713388	F	Hypoglycemic activity at dose 150 mg/Kg in KK-mice after peroral administration	Mus musculus	15		organism-based format	Scientific Literature
10.	ALA717777	F	Percent plasma glucose concentration of drug treated mice (ob/ob) relative to vehicle control animals	Mus musculus	67		organism-based format	Scientific Literature
11.	ALA714392	F	Antihyperglycemic activity was determined by measuring percent decrease in plasma glucose at 100 mg/kg/day	Mus musculus	1		organism-based format	Scientific Literature
12.	ALA719038	F	In vivo activity against hypocholesterol (CHOL) by using Alloxan-induced hyperlipoperoxidemia method in BALB/c mice after peroral administration at 100 mg/Kg dose	Mus musculus	10		organism-based format	Scientific Literature
13.	ALA719043	F	In vivo activity against serum lipid peroxidation level (s-LPO) by using Alloxan-induced hyperlipoperoxidemia method in BALB/c mice after peroral administration at 100 mg/Kg dose	Mus musculus	10		organism-based format	Scientific Literature
14.	ALA716090	F	In vivo activity against triglycerides (TG) by using Alloxan-induced hyperlipoperoxidemia method in BALB/c mice after peroral administration at 100 mg/Kg dose	Mus musculus	10		organism-based format	Scientific Literature
15.	ALA719434	F	percentage change in plasma glucose concentration of drug treated mice relative to vehicle controls at 100 mg/kg (once daily perorally x 4) in groups of db/db mice compared to vehicle control	Mus musculus	8		organism-based format	Scientific Literature
16.	ALA723763	F	Minimum effective dose for anti-hyperglycaemic activity was determined in C57B1/6 ob/ob obese mouse	Mus musculus	8		organism-based format	Scientific Literature
17.	ALA723772	F	Minimum effective dose required for significant reduction in blood glucose in ob/ob mice	Mus musculus	8		organism-based format	Scientific Literature
18.	ALA724363	F	Activity of perorally administered compound at a dose of 20 mg/kg for 10 days against plasma glucose in diabetic mice	Mus musculus	3		organism-based format	Scientific Literature
19.	ALA724364	F	Activity of perorally administered compound at a dose of 20 mg/kg for 4 days against plasma glucose in obese mice	Mus musculus	15		organism-based format	Scientific Literature
20.	ALA724365	F	Activity of perorally administered compound at a dose of 75 mg/kg for 4 days against plasma glucose in diabetic mice	Mus musculus	3		organism-based format	Scientific Literature